Canada Insulin Delivery Market Outlook to 2022

GlobalData
47 Pages - GLDATA57698
$4,995.00

Summary

GlobalData’s new report, "Canada Insulin Delivery Market Outlook to 2022", provides key market data on the Canada Insulin Delivery market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Insulin Delivery market segments - Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.
- Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.
- 2015 company shares and distribution shares data for each of the market segements.
- Global corporate-level profiles of key companies operating within the Canada Insulin Delivery market.
- Key players covered include Medtronic plc, Becton Dickinson and Co, Eli Lilly and Company, Novo Nordisk A/S and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned

Eli Lilly and Company
Becton Dickinson and Co
Sanofi
Medtronic plc
Novo Nordisk A/S
F. Hoffmann-La Roche Ltd

'

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Insulin Delivery Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Insulin Delivery Market, Canada 8
3.1 Insulin Delivery Market, Canada, Revenue ($m), 2008-2015 8
3.2 Insulin Delivery Market, Canada, Revenue ($m), 2015-2022 10
3.2.1 Insulin Pens Market, Canada, Revenue ($m), by Segment, 2008-2015 12
3.2.2 Insulin Pumps Market, Canada, Revenue ($m), by Segment, 2008-2015 14
3.2.3 Insulin Pens Market, Canada, Revenue ($m), by Segment, 2015-2022 16
3.2.4 Insulin Pumps Market, Canada, Revenue ($m), by Segment, 2015-2022 18
3.3 Insulin Delivery Market, Canada, Volume (Units), 2008-2015 20
3.4 Insulin Delivery Market, Canada, Volume (Units), 2015-2022 22
3.4.1 Insulin Pens Market, Canada, Volume (Units), by Segment, 2008-2015 24
3.4.2 Insulin Pumps Market, Canada, Volume (Units), by Segment, 2008-2015 26
3.4.3 Insulin Pens Market, Canada, Volume (Units), by Segment, 2015-2022 28
3.4.4 Insulin Pumps Market, Canada, Volume (Units), by Segment, 2015-2022 30
3.5 Insulin Delivery Market, Canada, Average Price ($), 2008-2022 32
3.6 Insulin Delivery Market, Canada, Distribution Share by Revenue ($m), 2014-2015 34
3.7 Insulin Delivery Market, Canada, Company Share by Revenue ($m), 2015 35
4 Overview of Key Companies in Canada, Insulin Delivery Market 37
4.1 Eli Lilly and Company 37
4.1.1 Company Overview 37
4.2 Becton Dickinson and Co 37
4.2.1 Company Overview 37
4.3 Sanofi 37
4.3.1 Company Overview 37
4.4 Medtronic plc 38
4.4.1 Company Overview 38
4.5 Novo Nordisk A/S 38
4.5.1 Company Overview 38
4.6 F. Hoffmann-La Roche Ltd 38
4.6.1 Company Overview 38
5 Insulin Delivery Market Pipeline Products 39
6 Financial Deals Landscape 40
6.1 Partnerships 40
6.1.1 Metabolon Enters into Licensing Agreement with Synlab 40
7 Recent Developments 41
7.1 Corporate Communications 41
7.1.1 Mar 23, 2016: Renowned scientist will lead rare mission to address the epidemic of heart failure 41
7.2 Other Significant Developments 41
7.2.1 Oct 20, 2016: JDRF and the University of Toronto support research into a skin patch to prevent common, life-threatening risk of T1D 41
8 Appendix 43
8.1 Research Methodology 44
8.1.1 Coverage 44
8.1.2 Secondary Research 44
8.1.3 Primary Research 45
8.1.4 Company Share Analysis 45
8.1.5 Distribution Share Analysis 45
8.1.6 Benchmarking 46
8.2 GlobalData Consulting 46
8.3 Contact Us 46
8.4 Disclaimer 47

1.1 List of Tables
Table 1: Insulin Delivery Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 9
Table 2: Insulin Delivery Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 11
Table 3: Insulin Pens Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 13
Table 4: Insulin Pumps Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 15
Table 5: Insulin Pens Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 17
Table 6: Insulin Pumps Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 19
Table 7: Insulin Delivery Market, Canada, Volume (Units), Historic, 2008-2015 21
Table 8: Insulin Delivery Market, Canada, Volume (Units), Forecast, 2015-2022 23
Table 9: Insulin Pens Market, Canada, Volume (Units), Historic, 2008-2015 25
Table 10: Insulin Pumps Market, Canada, Volume (Units), Historic, 2008-2015 27
Table 11: Insulin Pens Market, Canada, Volume (Units), Forecast, 2015-2022 29
Table 12: Insulin Pumps Market, Canada, Volume (Units), Forecast, 2015-2022 31
Table 13: Insulin Delivery Market, Canada, Average Price ($) Historic, 2008-2022 32
Table 14: Insulin Delivery Market, Canada, Average Price ($), Forecast, 2015-2022 33
Table 15: Insulin Delivery Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2014-2015 34
Table 16: Insulin Delivery Market, Canada, Company Share by Revenue ($m), USD Constant, 2015 36
Table 17: Insulin Delivery Market Pipeline Products 39
Table 18: Metabolon Enters into Licensing Agreement with Synlab 40

1.2 List of Figures
Figure 1: Insulin Delivery Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 8
Figure 2: Insulin Delivery Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 10
Figure 3: Insulin Pens Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 12
Figure 4: Insulin Pumps Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015 14
Figure 5: Insulin Pens Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 16
Figure 6: Insulin Pumps Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022 18
Figure 7: Insulin Delivery Market, Canada, Volume (Units), Historic, 2008-2015 20
Figure 8: Insulin Delivery Market, Canada, Volume (Units), Forecast, 2015-2022 22
Figure 9: Insulin Pens Market, Canada, Volume (Units), Historic, 2008-2015 24
Figure 10: Insulin Pumps Market, Canada, Volume (Units), Historic, 2008-2015 26
Figure 11: Insulin Pens Market, Canada, Volume (Units), Forecast, 2015-2022 28
Figure 12: Insulin Pumps Market, Canada, Volume (Units), Forecast, 2015-2022 30
Figure 13: Insulin Delivery Market, Canada, Company Share (%) 2015 35

$4,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports